Your full-service CDMO for complex dosage forms​ AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO

83 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Medical cannabis: from seed to purified pharmaceutical grade active ingredients Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, …

75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Biosimilar Experts Who we are Formycon AG is a leading, independent developer of high-quality biosimilars, follow-on products of biopharmaceutical medicines. The company focuses on therapies in ophthalmology, immunology, immuno-oncology and other key disease areas, covering almost the entire value chain from technical development through clinical trials to approval by the regulatory authorities. For commercialization of its biosimilars, Formycon relies on strong, well-trusted and long-term partnerships worldwide. About Biosimilars: Since their introduction in the 1980s, biopharmaceutical drugs have revolutionized the treatment of serious and chronic diseases. By 2032, many of these drugs will lose their patent protection – including 45 …

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Expert services in supercritical CO2 and nanomedicines for the life science industry StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO drug delivery, supercritical fluids, formulation, nanoparticles, GMP manufacturing, poorly soluble drugs, sterilization, impregnation, …

70 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

An expert team helping biotechs bring their drugs to and through clinical trials as efficiently as possible. Your expert team from concept to clinic. At Leads to Development, we use our knowledge and expertise to help biotechs bring their drugs to and through clinical trials as efficiently as possible, delivering value for companies and life-changing outcomes for patients. With decades of experience, more than 180 projects under our belt throughout Europe and the US, and a 100% success rate in obtaining clinic trial authorisations, our team provides comprehensive end-to-end support across all areas of new drug development. Our backgrounds are …

116 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Improving life for cancer patients through transformative drugs Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients. Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a smart, targeted chemotherapy designed to selectively treat liver cancer cells and to minimize side effects. Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership. Medivir's share …

65 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Pioneers in complex formulation · Ascil Biopharm is a clinical-stage biotechnology company specializing in innovative drug delivery solutions. We operate as a CDMO, fully equipped for early-stage drug product development, with a GMP facility for clinical batch manufacturing, (aseptic process and terminal sterilization) to fill various containers (e.g. vials, syringes). Our capabilities extend to formulation, device, and analytical development. · Our proprietary Controlled-Release Formulation (CRF) platform technology, is designed to improve the Phy-Chem properties of APIs and excipients under injection conditions, enabling the development of ready-to-use (RTU) controlled-release formulations and ultra-high concentration (UHC) drug products. · Our expertise covers a …

141 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Cultivating Australian-grown medicines. GMP certified. Built in the Noosa Hinterland in Queensland, PharmaCrop combines international cultivation expertise with Australian production and GMP-certified manufacturing. Our integrated approach brings key stages of cultivation, processing and manufacturing together, supporting quality, consistency and oversight from cultivar selection through to finished product. The result is a growing portfolio of Australian-grown products shaped by global knowledge and pharmaceutical discipline. Pharmaceutical, Retail Pharmacy, Healthcare, Plant Based Medicine, Australian Manufacturing, and Australian Medicinal Cannabis

104 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Health for the future we dream of. Since 1988 in the area of ​​nephrology, Farmarin has been a pioneer in the production of Polyelectrolyte Concentrates for Hemodialysis - CPHD in the national market. Initially established to supply some hemodialysis clinics in the city of São Paulo, it has experienced exponential growth over the years, meeting the growing demand for its products. In 2000, it moved its facilities to the city of Guarulhos, starting to produce on an industrial scale to serve the national and international market. Currently, it invests in new products to serve the hospital sector in the country. …

95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannabis-based medicines. Celadon Pharmaceuticals Plc is a UK based pharmaceutical company focused on the research, cultivation, manufacturing, and supply of breakthrough cannabis-based medicines. Founded in 2018 after cannabis was legalised for medicinal purposes, Celadon was one of the first companies to receive Home Office and MHRA licences to cultivate and produce high-THC medicines. In March 2022, Celadon listed on the AIM market of the London Stock Exchange – a huge milestone in the industry and the first since GW Pharma (who were acquired for $7bn by Jazz in 2021). …

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making the most innovative therapies possible for everyone. Medios is a leading specialty pharmaceutical company and pioneer of individual medicine. Together with pharmacies, doctors and pharmaceutical companies, we ensure a safe and reliable supply of medicines for complex and serious illnesses. As a pharmaceutical supplier and GMP manufacturer of patient-specific therapies, we connect all relevant players in the healthcare market in a strong network. In this way, we make it possible for specialized medicines to arrive exactly where they are needed. Our focus is on the production and provision of patient-specific therapies as well as an efficient supply structure for …

130 similar entities Type: Startup Activities: healthtech Technologies: Data Analytics

A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty …

120 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Committed to Science. Committed to you. Complife is an international group that provides consulting and testing services for cosmetics, nutraceuticals, medical devices & pharma. We support our Clients to assess the safety, tolerability and efficacy of products, as well as their chemical and microbiological features and our Regulatory staff offers a total support for compliance: from R&D through production, distribution, up to market support. Thanks to the distribution of subsidiaries and labs our experts can have a worldwide view regarding trends and regulatory issues, while our local laboratories ensure a focused and totally tailored reply to the clients. From September …

105 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder …

102 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Beemine® is transforming pain relief solutions through Cannabis. Beemine® is a design healthcare startup specialized in developing, producing, and selling products based on emerging active ingredients such as cannabis and nootropics, with high potential benefits for human health. We design natural synergies for pain relief and operate in the export of APIs for the formulation of medical cannabis in regulated European markets. Innovación, Techfood, Bees, Honey, CBD, Alimentación, Apicultura, Agricultura, Cañamo industrial, Diseño, Foodlab, and Cosmética

64 similar entities Type: Startup Activities: healthtech Technologies: Bio sourced materials

Non-profit association, which brings together professionals from the pharmaceutical industry sector Established in 1976, the Spanish Association of Industrial Pharmacists is a technical-scientific association that brings together professionals who, from various fields, work in the pharmaceutical industry, institutions or entities linked to the pharmaceutical and health sector (medicines, cosmetics, food, medicinal plants, health products, etc.). Visit our blog 💻 https://www.aefi.org/blog/ Sign up for our training 📚 https://aefi.org/calendario-formaciones/ Pharmacy, Pharmaceutical Industry, Health Products, Medical Technology, Regulations, Quality, Training, GxP, EMA, Cosmetics, Veterinary, AEMPS, FENIN, Farmaindustria, Pharmatech, Veterindustria, Galénica, FDA, Registries, Work Groups, Employment Exchange, Networking, Symposium, Pharmacovigilance, Clinical Research, Food Safety, …

119 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: New Materials

GCS is Connecting Demand to Supply with a Vertically Integrated Platform Business Model Our vertical integrated ecosystem makes GCS the Gatekeeper in Germany * GCS Cultivation is building the largest German cultivation facility for medical cannabis to provide high quality strains, “Made‐in‐Germany”, to pharmacies that outperforms on freshness & consistency * Blütezeit is our own telemedicine platform providing legal and compliant access to medical cannabis by connecting doctors to patients. It serves as the patient-facing brand and primary patient gateway. * Cannaflow`s B2B software and marketplace empowers pharmacies to manage, distribute and connect cannabis via multiple channels, e.g. wholesale partners, …

72 similar entities Type: Startup Activities: healthtech Technologies: SaaS

Pragati Healthcare India is a global exporter and distributor of Anti-cancer, Diabetes, Hepatitis, Cardiac, Sexual Health, HIV, Ophthalmic and OTC products. Our family has been into pharmaceutical distribution for over 50 years now and have significant presence in UK & Hong Kong. We have direct tie ups with reputed pharma companies like Pfizer, AstraZeneca, Novartis, Novo Nordisk, Eli Lilly, Bayer, Abbott, Boehringer Ingelheim, Sanofi, Sun Pharma, Natco, Cipla, Lupin, Intas and others. For other companies, we source from vendors after careful research about their repute and history. Cancer Medicines Exporter, Unlicensed Medicines, Parallel Exports, Europe Medicine Supplier, Named Patient Medication, …

60 similar entities Type: Startup Activities: biotech deeptech

Boosting Survival Through Innovative Immune Modulation MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed …

71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These …

164 similar entities Type: Startup Activities: it services manufacturing Technologies: Synthetic Biology

Serving patients and research. French hub for medical cannabis and dermo-cosmetics innovation Created in 2014 by a patient, DelleD develops Laboratoires LaFleur, the first French pharmaceutical laboratories specializing in medical cannabis & hortimind, an AI-assisted plant production solution. LaFleur aims to promote research and development of medical cannabis in France and internationally and to defend the evolution of the legal framework relating to the production, cultivation and use of cannabis for medical use. The laboratories cultivate, transform, control and manufacture medicines based on medical cannabis as part of research and development in France. Expert in plant health, the laboratories use …

65 similar entities Type: Startup Activities: manufacturing deeptech healthtech biotech Technologies: Synthetic Biology

Dosepharma, the blistering service provider for pharmacists. Founded in 2013, Dosepharma specializes in the packaging of medicines (Blistering). Certified by Swissmedic, our company stands out for offering personalized, high-quality Blistering services. In our laboratory, doses of personalized medications are placed in blister packs in a robotic, highly controlled manner and in compliance with the highest safety standards. We work on a daily basis to relieve patients in their medication intake and allow pharmacists to benefit from a tailor-made service for their patients. Technology, Automation, Medicine, Digital, Pharmacy, IT, challenger mindset, and unit sales

62 similar entities Type: Startup Activities: it services Technologies: Synthetic Biology

Award-winning cannabis brands & products. Crafted with pride, by people who care. Entourage Health Corp. is a licence holder and producer of cannabis products for both the medical and adult-use markets. The company operates a fully-licensed 26,000 sq. ft. Aylmer, Ontario-based processing and distribution facility. With the addition of Starseed Medicinal, a medical-centric brand. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups. Entourage’s adult-use product portfolio that includes Color Cannabis, Dime Bag and Saturday Cannabis - sold across eight provincial distribution agencies. Production of Quality Medical Cannabis, Distribution of …

62 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Pyramid studio embodies an unique way of leading therapeutic innovation to fuel the pipeline of pharmaceutical companies Pyramid Studio is a First-of-its-Kind venture builder dedicated to fuel the pipeline of pharmaceutical companies Pyramid Studio embodies a new way of leading therapeutic innovation through a unique build-to-buy model. Our mission is to bridge the gap for pharmaceutical companies seeking access to breakthrough innovations and delivering new therapies to patients. In practice, our team identifies and rigorously selects groundbreaking innovations from top academic teams across Europe. We collaborate closely with our Pharma partners to co-develop and co-finance these programs, ultimately delivering IND-ready …

293 similar entities Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Synthetic Biology

Contract manufacturing of medicinal cannabis extracts. Valcon Medical is EU-GMP certified. Valcon Medical A/S is a Danish-based contract manufacturing company founded in December 2018. We provide contract processing services, white label products, and supply of raw material to our outsourcing partners and customers in the European medicinal cannabis industry. Contract Manufacturing of Pharmaceutical-Grade Cannabis Extracts. Valcon Medical is Licensed under the Danish Cannabis Pilot Program. European Union Good Manufacturing Practice (EU GMP) certification for the manufacturing of medical cannabis extracts in compliance with the German Monograph for cannabis extracts, DAB Eingestellter Cannabisextract as of May, 2021. On January 1, 2018, …

57 similar entities Type: Startup Activities: healthtech deeptech manufacturing Technologies: New Materials

Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition …

577 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

The Beauty of Chemistry Established in 1991 in Hyderabad, India, Vivimed Labs has metamorphosed from a domestic small, entrepreneurial family-operated business to a globally renowned supplier of niche molecules and formulations across Healthcare, Pharmaceuticals and Specialty Chemicals consumers in nearly 50 countries. Driven by our philosophy of using chemistry as a base to create ingredients which touch human life on a day to day basis, Vivimed Labs delivers world-class products across the various segments we serve. The active ingredients manufactured by us are the preferred ingredients in Home & Personal care segments such as hair, skin, oral care and anti-microbial …

71 similar entities Type: SMB Activities: manufacturing Technologies: Semiconductors

Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more …

225 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Creation and implementation of innovative therapeutic solutions derived from cannabinoid biomolecules. Since the entry into common law of medical cannabis in September 2023, the development of new drugs has been at the center of the pharmaceutical industry's concerns. Chenevia is a French Biotech startup, financed by Breton investors, subsidized by the Brittany Region, supported by Crédit Agricole via the Village by CA Morbihan accelerator and active member of Santé France Cannabis (privileged consultant to the Government on the regulation of medical cannabis). The 3 co-founders have skills combining technique, pharmaceutical expertise and compliance with regulatory constraints. We are committed to …

140 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

We Craft Care SOMAÍ is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine. SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that …

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university …

85 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Organically grown, lab-tested, full-spectrum Oils, Extracts, Edibles, and Capsules. Holistic Hemp Scotland improves the health and standard of living for thousands of people across the UK and EU by providing access to only the highest quality, organic, Cannabis products. We are here to educate, to guide and to provide relentless quality to the customers who rely on our products to live the best version of their lives. Cannabis, CBDOils, CBDEdibles, CBDExtracts, Hemp, Health & Wellbeing, and Product Testing

71 similar entities Type: Startup Activities: healthtech Technologies: Bio sourced materials

A leading specialist in injectables As a responsible and committed laboratory, our ambition is to be an independent European leader in the field of essential medicines. Our mission for 40 years: acting together, every day, to guarantee patients reliable access to essential medicines. We develop, produce and market injectable generic medicines for hospitals and clinics in France and in more than 75 countries on 5 continents. Through three production sites in France and Germany, we specialize in the fields of generic injectable antibiotics, anesthetics and analgesics. As a responsible laboratory with a long-term vision, we have decided to invest more …

69 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and consumer health products. Sanity Group, a Berlin based cannabis company, is dedicated to the medicinal and health use of cannabinoids. Sanity's operations span from medicinal cannabis to consumer health and tech. We believe that everyone deserves to live a healthy life and therefore develop and distribute innovative, cannabinoid-based pharmaceuticals and wellbeing products to patients and customers around Europe. We are looking for partners with cultivation facilities around the world, that would like to expand their European footprint. You can reach our Imprint (EN) here: https://sanitygroup.com/imprint/ DE: Über diesen Link erreichen …

67 similar entities Type: Startup Activities: deeptech healthtech

Zerion Pharma is a pharmaceutical company transforming the landscape for formulation of poorly soluble drugs Zerion is a pharmaceutical company transforming the pharmaceutical landscape for formulation of poorly soluble drugs that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, we aim to develop new treatment options for patients across all small molecule therapy areas. We are focused on improving existing drug products by building an internal pipeline, while partnering with originators to enable their early stage drug molecules, striving to improve the lives of patients around the world. Pharmaceuticals, Formulation, and Drug delivery

184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The German Medical Cannabis Expert DEMECAN is the German market leader for medicinal cannabis. As pioneers in the industry, DEMECAN stands as Germany's premier provider of medicinal cannabis. We specialize in the sustainable cultivation and wholesale of medicinal cannabis, offering comprehensive solutions for the German medical cannabis industry. Our focus lies in quality, innovation, and service. With an unwavering goal of providing patients across Germany with top-tier medicinal cannabis, we continuously strive to enhance the quality of life for our customers and broaden access to safe, effective, and sustainable cannabis products. Impressum: https://www.demecan.de/impressum/

61 similar entities Type: Startup Activities: deeptech healthtech Technologies: Decarbonization

Unlocking the potential of cannabis medicines for those who need it. Unlocking the potential of cannabis medicines for those who need it. Our Market Access Team launches medical cannabis producers'​ businesses into new markets to create long-term value for them. Our R&D Team creates new technologies for medical cannabis producers to create better, cost-effective, accessible medicines for patients. By combining our strengths as scientists, technologists, and commercial strategists, we create game-changing Intellectual Property that will transform the fastest growing industry in the world, medical cannabis. Find all our links at: https://growgroup.komi.io Cannabis Biotech, Medical Cannabis, Research & Development, Technology, Biotech, …

61 similar entities Type: Startup Activities: deeptech healthtech manufacturing

Your CDMO for API solutions since 1970 | Our excellence, your trust #OEYT At Seratec, APIs are more than a science. They are a passion. Entrepreneurs in pharmaceutical chemistry since 1970, we produce active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. Drawing on internationally recognized French know-how, we design, develop, produce and register files for pharmacologically active molecules with the American (FDA), European (EMA) and national (ANSM) drug agencies. To offer the best services, we also ensure the production of APIs according to quality standards known as Good Manufacturing Practices (GMP 2 or cGMP). The pharmaceutical …

121 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by …

144 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Decarbonization

Sterile Solutions, Built Differently. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health Subscribe our newsletter: www.ten23.health/ten23-health-newsletter biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development

412 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South …

202 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

dedicated to good health® Genix Pharma (Pvt.) Ltd is a leading Pharmaceutical manufacturer & marketing company, based in Pakistan with its business expanding throughout Asian & African Markets, after its establishment in 2004, Genix Pharma has been recognized as the fastest growing Pharmaceutical Company in its earliest years, it has been ranked among the top 40 companies including MNC’s, We have a work force of more than 1400 professionally trained and highly qualified employees, state of the art manufacturing facility, Well-furnished Quality Control department with top of the line and highly sophisticated Equipment, motivated by a passion to succeed, our …

96 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Europhartech, a company of the Dômes Pharma group Production site of the Dômes Pharpe Europhartech Group is also CMO (Contracting Organization contract) for the human and veterinary pharmaceutical industry. Specialized in clinical lots, the production of dry forms and non -sterile liquid forms for human and veterinary use as well as in food supplements, additional food and medical devices. Europhartech also has solid expertise from Princeps, ATU/AMM Hospital and EHPAD Unit Bud, PDA, Generic and Nutraceutic. Europhartech is a subsidiary of the pharmaceutical group Dômes Pharma specializing in animal health and present in human health since 1992. Laboratory approved by …

206 similar entities Type: SMB Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Analyse pharmaceutique, Pharmaceutical analysis, Contract Research Organization (CRO), Développement analytique, Contrôle qualité pharmaceutique, Quality control (QC), Method development, Analytical method validation, ICH guidelines, ICH Q2 / ICH Q14, Validation analytique, Transfert de méthodes, Biopharmaceuticals, Small molecules, sterile products, Vaccins, Stability studies, Regulatory affairs, GMP compliance, GLP compliance, CCIT (Container Closure Integrity Testing), Extractables & Leachables, Elemental impurities …

135 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

In Pursuit of Answers Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020. Learn more at www.Labcorp.com Drug Development Services , Toxicology Services, Central Labs, Central Laboratory Services , Clinical Trial Management , CRO …

213 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

SAFETY + FAIRNESSTM Hound Labs, Inc. develops advanced breath testing technologies to address leading public health and safety issues. The Company’s flagship product, the HOUND® CANNABIS BREATHALYZER, introduces the drug testing industry’s shortest cannabis detection window, giving employers a practical and objective solution to detect and deter recent use. The ultra-sensitive, analytical test identifies active THC molecules in breath, limiting cannabis detection to the workday. As cannabis legalization increases employee access to THC, employers are seeking a solution to continue testing for the drug while balancing workplace safety with employee fairness and privacy. Hound Labs’ groundbreaking innovation returns an objective …

53 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A vertically integrated pharma company; specialized in the development & manufacture of APIs, FDFs and CDMO services. Medichem is a vertically integrated pharmaceutical company and certified B Corp, combining nearly 50 years of industry expertise with a strong commitment to scientific excellence, quality, and sustainability. We develop and manufacture both APIs (Active Pharmaceutical Ingredients) and FDFs (Finished Dosage Forms) for the global generics market. Our portfolio includes around 45 APIs and 20 FDFs, and we are recognized as a world leader in Chlorhexidine-based products. In addition to our product range, we provide comprehensive services including R&D, contract manufacturing, and licensing …

59 similar entities Type: SMB Activities: deeptech manufacturing

CRO with extensive expertise in small molecule chromatography and purification We are Neopharm Boston Inc., formerly Averica Discovery Services, a Contract Research Organization (CRO) recognized by our proficiency in small molecule analysis and purification. Our enduring legacy of excellence positions us as a strategic partner within the pharmaceutical industry. Our recent expansion has equipped us to deliver a comprehensive, fully integrated array of services, facilitating a seamless journey from development and preclinical stage to commercial launch. At Neopharm Boston, our remarkable high throughput capabilities extend beyond advanced instrumentation to encompass a highly skilled and capable team. This synergy enables us …

139 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Our mission is to empower global research that unlocks life-changing solutions and inspires a meaningful life. MP Biomedicals is dedicated to giving scientists and researchers innovative, quality tools and superior service to aid them in their quest for ground-breaking discovery and turning the hope for life-changing solutions into a reality. The company manufactures and sells more than 55,000 products and is one of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products. MP Biomedicals is a world-wide corporation, with ISO-certified and FDA-approved manufacturing and distribution facilities throughout the globe and …

63 similar entities Type: SMB Activities: deeptech biotech

Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in clinical stage of development. erectile dysfunction, biopharma, premature ejaculation, drug development, pharma, sexual health, lifestyle , drug discovery, lifestyle, drug discovery, drugs from nature, and biopharmaceutical

100 similar entities Type: Startup Activities: manufacturing deeptech biotech healthtech Technologies: Synthetic Biology

Innovation in Marine-Derived Oncology Therapies Headquartered in Madrid, PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes its inspiration from the sea to discover molecules with antitumor activity. It is a company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. Its commitment to patients and to research has made it one of the world leaders in the discovery of antitumor drugs of marine origin. PharmaMar has a pipeline of drug candidates and a robust R&D oncology program. It develops and commercializes Yondelis® in Europe and has other …

119 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Unlock Possibility. Spark Innovation. We use science to reveal greater potential in our cannabis and hemp clients. Veda Scientific’s mission is to build the most trusted cannabis and hemp testing services, always deliver on our promises and focus on our customers’ success, not just our own. We work with INNOVATORS. Our customers chose the Central Coast because it has the infrastructure, talent and climate to build the best cannabis operations in the world. We believe INNOVATION is the key to success in the cannabis industry, but as a cannabis and hemp testing laboratory, we’re not the hero of this story. …

51 similar entities Type: Startup Activities: healthtech deeptech

Unlock the potential of your drug with our expertise in Transdermal and complex Injectable product development Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the …

172 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large …

257 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Working to keep you healthy. The MIP Pharma Group (MIP Pharma) produces and sells prescription-only generics, specifically antibiotics, over-the-counter medicines and medical devices. The main markets are Germany and Poland and some other Eastern European markets. MIP Pharma has two production facilities in Saarland/Germany. With around 250 employees, MIP Pharma realised a total turnover of more than €40 million during the last business year. Contact: info@mip-pharma.de Generika, Antibiotika, OTC-Arzneimittel, and Medizinprodukte

63 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Efficiency at the service of your well-being LABIANA Pharmaceuticals has an extensive experience in contract manufacturing services for the human pharmaceutical industry and provides services to many important multinational companies. Under the EU-GMP certificate, LABIANA Pharmaceuticals has a production plant with current authorisation for several pharmaceutical forms including tablet manufacturing and with a capacity of about 20 million units. Among other expertises, LABIANA has Film Coating Technology (FCT) available and a strong packaging capability including 7 packaging lines. LABIANA Pharmaceuticals registered several marketing authorisations worldwide. With a competitive and highly trained team spread among the Technical, Regulatory Affairs and Research …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Our Experience, Your Success: A full-service IVD CRO partner delivering clinical, regulatory and quality expertise For over three decades, MDC has been the expert CRO partner for diagnostic innovators bringing critical tests to market. We understand and can anticipate challenges along the way. That is why we identify obstacles early, minimize risks with pristine execution, and guide your team through the essential steps to market authorization. Whether you need clinical, regulatory, or quality support, we develop and deliver tailored solutions to meet your needs. We have delivered over 150 successful FDA submissions and managed more than 100 clinical studies across …

177 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

AQSE-listed company whose ambition is to be a leading provider of cannabinoid medicines for chronic pain conditions. Developer of cannabinoid-based medicines for the treatment of complex, chronic, inflammatory pain conditions. Patent pending formulation being used in two fully funded Phase II RCTs at Edinburgh University. Sale of two cannabidiol formulations through UK based medical cannabis pharmacy networks. Please contact for more info. research, science, and medicalcannabis

67 similar entities Type: Startup Activities: deeptech